An integrated strategy for the discovery of drug targets by the analysis of protein-protein interactions

被引：3

作者：

Peltier, JM ^{[1
]}

Askovic, S ^{[1
]}

Becklin, RR ^{[1
]}

Chepanoske, CL ^{[1
]}

Ho, YSJ ^{[1
]}

Kery, V ^{[1
]}

Lai, SP ^{[1
]}

Mujtaba, T ^{[1
]}

Pyne, M ^{[1
]}

Robbins, PB ^{[1
]}

von Rechenberg, M ^{[1
]}

Richardson, B ^{[1
]}

Savage, J ^{[1
]}

Sheffield, P ^{[1
]}

Thompson, S ^{[1
]}

Weir, L ^{[1
]}

Widjaja, K ^{[1
]}

Xu, NF ^{[1
]}

Zhen, YJ ^{[1
]}

Boniface, JJ ^{[1
]}

机构：

[1] Prolexys Pharmaceut Inc, Salt Lake City, UT 84116 USA

来源：

INTERNATIONAL JOURNAL OF MASS SPECTROMETRY | 2004年 / 238卷 / 02期

关键词：

protein interactions; MS/MS; affinity tags; drug discovery; drug targets;

D O I：

10.1016/j.ijms.2003.12.039

中图分类号：

O64 [物理化学（理论化学）、化学物理学]; O56 [分子物理学、原子物理学];

学科分类号：

070203 ; 070304 ; 081704 ; 1406 ;

摘要：

Proteomics-based technologies have the potential to accelerate the development of drugs, but such technologies must be well integrated in order to have a positive impact. We describe, herein, a multi-step process for the discovery of protein-protein interactions. It is shown that process stages are interdependent and can influence, either positively or negatively, subsequent steps. Optimization of each step, in the context of the full process, is essential for the overall success of the experiment. (C) 2004 Elsevier B.V. All rights reserved.

引用

页码：119 / 130

页数：12

共 50 条

[31] Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening
Magee, Thomas V.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (12) : 2461 - 2468
[32] Unlocking the secrets to protein-protein interface drug targets using structural mass spectrometry techniques
Dailing, Angela
Luchini, Alessandra
Liotta, Lance
EXPERT REVIEW OF PROTEOMICS, 2015, 12 (05) : 457 - 467
[33] From Protein-Protein Interactions to Rational Drug Design: Are Computational Methods Up to the Challenge?
Coelho, Edgar D.
Arrais, Joel P.
Oliveira, Jose Lus
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (05) : 602 - 618
[34] Targeting protein-protein interactions for cancer therapy
Fry, DC
Vassilev, LT
JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (12): : 955 - 963
[35] Targeting Protein-Protein Interactions in Hematologic Malignancies
Cierpicki, Tomasz
Grembecka, Jolanta
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2025, 20 : 275 - 301
[36] Modulating protein-protein interactions: the potential of peptides
Nevola, Laura
Giralt, Ernest
CHEMICAL COMMUNICATIONS, 2015, 51 (16) : 3302 - 3315
[37] Tailoring Peptidomimetics for Targeting Protein-Protein Interactions
Akram, Omar N.
DeGraff, David J.
Sheehan, Jonathan H.
Tilley, Wayne D.
Matusik, Robert J.
Ahn, Jung-Mo
Raj, Ganesh V.
MOLECULAR CANCER RESEARCH, 2014, 12 (07) : 967 - 978
[38] Strategies to Develop Inhibitors of Motif-Mediated Protein-Protein Interactions as Drug Leads
Corbi-Verge, Carles
Garton, Michael
Nim, Satra
Kim, Philip M.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57, 2017, 57 : 39 - 60
[39] Targeting Protein-Protein Interactions for Parasite Control
Taylor, Christina M.
Fischer, Kerstin
Abubucker, Sahar
Wang, Zhengyuan
Martin, John
Jiang, Daojun
Magliano, Marc
Rosso, Marie-Noelle
Li, Ben-Wen
Fischer, Peter U.
Mitreva, Makedonka
PLOS ONE, 2011, 6 (04):
[40] Allosteric Modulators of Protein-Protein Interactions (PPIs)
Ni, Duan
Liu, Na
Sheng, Chunquan
PROTEIN ALLOSTERY IN DRUG DISCOVERY, 2019, 1163 : 313 - 334

← 1 2 3 4 5 →